Diasome Pharmaceuticals Press Releases

• Published on February 29, 2024 - 19:02 GMT

  Diasome Pharmaceuticals Launches Groundbreaking OPTI-2 Phase 2b Trial in Type 1 Diabetes

  CLEVELAND, OH, UNITED STATES, February 29, 2024 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel liver targeting drug platform, announced today the initiation of the OPTI-2 Phase 2b …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on February 20, 2024 - 16:00 GMT

  Diasome Pharmaceuticals Appoints Peter Tollman, Ph.D., as Chairman of the Board

  CLEVELAND, OH, UNITED STATES, February 20, 2024 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel hepatocyte cell drug targeting platform, today announced the appointment of Peter Tollman, …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on December 7, 2023 - 19:39 GMT

  Diasome Pharmaceuticals Announces First Closing of Series C Financing Round

  Diasome Secures Series C Funding with Eli Lilly Participation CLEVELAND, OH, USA, December 7, 2023 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company that leverages a novel hepatocyte cell targeting platform …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on October 24, 2023 - 16:14 GMT

  Former Novo Nordisk Executive, Dr. Todd Hobbs, joins Diasome Pharmaceuticals as Chief Medical Officer

  Dr. Todd Hobbs, Former North American Chief Medical Officer at Novo Nordisk, to Guide Diasome's HDV Platform Expansion CLEVELAND, OH, UNITED STATES, October 24, 2023 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a clinical-stage …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on June 21, 2023 - 13:26 GMT

  Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

  CLEVELAND , OH, UNITED STATES, June 21, 2023 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a global leader in the development of innovative therapeutics for diabetes, is pleased to announce that the company's Chief Medical Officer, Dr. Marc …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on June 2, 2022 - 14:30 GMT

  Diasome's HDV-Insulin demonstrates substantial Level 2 hypoglycemia reductions in setting of increased insulin use

  The OPTI-1 trial shows increasing liver-targeted bolus insulin restores liver physiology allowing subjects to decrease Level 2 hypoglycemia by 50% at nighttime CLEVELAND, OH, UNITED STATES , June 2, 2022 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on January 13, 2022 - 16:49 GMT

  Diasome announces appointment of biopharma thought leader and CEO advisor Peter Tollman, PhD as a new Board Member.

  CLEVELAND , OHIO , UNITED STATES, January 13, 2022 /⁨EINPresswire.com⁩/ -- Diasome Pharmaceuticals, Inc., a life sciences company focused on the development of novel therapies for the treatment of diabetes and other metabolic conditions, announced today …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...